"Raynaud Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Descriptor ID |
D011928
|
MeSH Number(s) |
C14.907.617.812
|
Concept/Terms |
Raynaud Disease- Raynaud Disease
- Cold Fingers, Hereditary
- Raynaud's Disease
- Raynauds Disease
|
Below are MeSH descriptors whose meaning is more general than "Raynaud Disease".
Below are MeSH descriptors whose meaning is more specific than "Raynaud Disease".
This graph shows the total number of publications written about "Raynaud Disease" by people in this website by year, and whether "Raynaud Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Raynaud Disease" by people in Profiles.
-
Acute Digital Necrosis in a Patient With Raynaud's Phenomenon and COVID-19 Infection. Am Surg. 2023 Apr; 89(4):1129-1132.
-
Botulinum Toxin Injection for Lower Face and Oral Cavity Raynaud Phenomenon After Mandibulectomy, Free Fibula Reconstruction, and Radiation Therapy. Ann Plast Surg. 2019 01; 82(1):53-54.
-
Advances in Upper Extremity Scleroderma Wound Care. Adv Skin Wound Care. 2018 Oct; 31(10):446-455.
-
Persistent cutaneous manifestations of hyperoxaluria after combined hepatorenal transplantation. Dermatol Online J. 2004 Jul 15; 10(1):10.
-
[Temporary hemiparesis and Raynaud symptoms in eosinophilic fasciitis]. Internist (Berl). 1997 Jul; 38(7):688-91.
-
Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome. J Rheumatol. 1995 Apr; 22(4):768-73.
-
Use of biofeedback training in treatment of Raynaud's disease and phenomenon. J Rheumatol. 1985 Feb; 12(1):90-3.
-
A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma. Arch Dermatol. 1984 Mar; 120(3):329-31.
-
Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit. Arch Dermatol. 1983 Sep; 119(9):733-5.
-
Neuroendocrine response to cold in Raynaud's syndrome. Life Sci. 1983 Feb 28; 32(9):995-1000.